| Salvage locoregional therapies for recurrent hepatocellular carcinoma |
| |
| 作者姓名： | Cody R Criss Mina S Makary |
| |
| 作者单位： | 1. Heritage College of Osteopathic Medicine, Ohio University;2. Department of Radiology, The Ohio State University Wexner Medical Center |
| |
| 摘 要： | Hepatocellular carcinoma(HCC) is the second most common cause of cancerrelated death worldwide. Despite the advent of screening efforts and algorithms to stratify patients into appropriate treatment strategies, recurrence rates remain high. In contrast to first-line treatment for HCC, which relies on several factors, including clinical staging, tumor burden, and liver function, there is no consensus or general treatment recommendations for recurrent HCC(R-HCC). Locoregional therapies include a s...
|
| 收稿时间： | September 4, 2022 |
Salvage locoregional therapies for recurrent hepatocellular carcinoma |
| |
| Cody R Criss,Mina S Makary.Salvage locoregional therapies for recurrent hepatocellular carcinoma[J].World Journal of Gastroenterology,2023,29(3):413-424. |
| |
| Authors: | Cody R Criss Mina S Makary |
| |
| Institution: | Cody R Criss, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio 45701, United StatesMina S Makary, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, United States |
| |
| Abstract: | Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. Despite the advent of screening efforts and algorithms to stratify patients into appropriate treatment strategies, recurrence rates remain high. In contrast to first-line treatment for HCC, which relies on several factors, including clinical staging, tumor burden, and liver function, there is no consensus or general treatment recommendations for recurrent HCC (R-HCC). Locoregional therapies include a spectrum of minimally invasive liver-directed treatments which can be used as either curative or neoadjuvant therapy for HCC. Herein, we provide a comprehensive review of recent evidence using salvage loco-regional therapies for R-HCC after failed curative-intent. |
| |
| Keywords: | Recurrent hepatocellular carcinoma Locoregional therapy Transarterial chemoembolization Transarterial embolization Transarterial radioembolization Ablation Salvage therapy |
|
| 点击此处可从《世界胃肠病学杂志(英文版)》浏览原始摘要信息 |
|
